Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

Francois Cedric reported 16 trades in Apellis Pharmaceuticals, Inc. shares (Form 4)

Traded May 14, 2026 · Filed May 14, 2026

On May 14, 2026, Francois Cedric (Director, Chief Executive Officer) reported 16 trades in Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).

Shares: 1,805,259 shares
Holding after: 0 shares
Trading plan: No
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 14, 2026	Common Stock	Other	425,968		0	Direct
May 14, 2026	Common Stock	Other	372,815		0	Indirect
May 14, 2026	Common Stock	Other	472,065		0	Indirect
May 14, 2026	Common Stock	Other	300,000		0	Indirect
May 14, 2026	Common Stock	Other	234,411		0	Indirect
May 14, 2026	Common Stock	Award	143,750		143,750	Direct
May 14, 2026	Common Stock	Disposition	143,750		0	Direct
May 14, 2026	Common Stock	Award	87,108		87,108	Direct
May 14, 2026	Common Stock	Disposition	87,108		0	Direct
May 14, 2026	Common Stock	Award	97,976		97,976	Direct
May 14, 2026	Common Stock	Disposition	97,976		0	Direct
May 14, 2026	Common Stock	Award	195,952		195,952	Direct
May 14, 2026	Common Stock	Disposition	195,952		0	Direct
May 14, 2026	Common Stock	Disposition	20,862		0	Direct
May 14, 2026	Common Stock	Disposition	36,047		0	Direct
May 14, 2026	Common Stock	Disposition	97,997		0	Direct

Source

View original at SEC

Related